Neural precursor cell-expressed developmentally downregulated gene 4 L (NEDD4L, also called NEDD4-2), which is identified as a HECT-type E3 ubiquitin ligase, is involved in the regulation of multiple substrates and mediation of drug sensitivity in diverse cancers [12]. The gene discussed is NEDD4L; the disease is cancer.